News

The grant is expected to be used to fund the study of mechanisms of cellular reprogramming with the specific aim of enhancing the efficiency of reprogramming techniques. Through

Panacea Biotec’s pharmaceutical formulation facility, spanning over 10,925m2, has blocks for oral solids, semi-solids and liquid oral dosage forms. The oral dosage form block has capability to manufacture

Dow Chemical has posted a net income of $552m for the first quarter 2010, or $0.41 per diluted share, compared to $35m, or $0.03 per diluted share, for

Wyatt Technology said that DynaPro facilitated the detection of aggregation in early stages of micellisation of pluronic polymeric surfactant due to temperature effects, pH, salinity concentration and composition.

As per the terms of the agreement, Protox is expected to receive an upfront payment of $3m and is eligible to receive a near term milestone payment of

Allergan has posted a net income of $169m for the first quarter of 2010, compared to $45m for the prior year period. Operating income was $250.3m, compared to

The quality agreement template was created to provide guidance for drafting agreements relating to the manufacture and release of drug substances regulated by the FDA. The template is

The license agreement is expected to enable Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient

Progen Pharmaceuticals said that it had recently terminated its previous agreement with Global Transbiotech and was looking for a partner that could complete product development and commercialisation of